insights_auto
Why is CSBR down 3,30%?
Dive Deeperchevron_right
CSBR:NASDAQ
Champions Oncology Inc
USD 4,44
arrow_downward
-3,30%(-0,15) 1D
18 Nov., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
USD 4,55
High
USD 4,60
Low
USD 4,41
Mkt. cap
61,82 m.
Avg. vol.
7,41 k
Volume
11,73 k
52-wk high
USD 8,31
52-wk low
USD 4,41
EPS
-USD 0,08
Beta
0,47
Shares outstanding
13,92 m.
No. of employees
217
Open
USD 4,55
High
USD 4,60
Low
USD 4,41
Mkt. cap
61,82 m.
Avg. vol.
7,41 k
Volume
11,73 k
52-wk high
USD 8,31
52-wk low
USD 4,41
EPS
-USD 0,08
Beta
0,47
Shares outstanding
13,92 m.
No. of employees
217
News stories
From web sources and news partners
seMissourian
·
1 uur gelede
Fifth straight drop for S&P 500 drags Wall Street to its longest losing streak since June
Hedgeye
·
13 uur gelede
Why Negative Gamma Has Taken the Brakes Off the S&P 500
Yahoo Finance
·
7 uur gelede
Forget Market Crashes: These Dow Jones Giants Have Recession-Proof Dividends
The Motley Fool
·
4 uur gelede
Stock Market Today, Nov. 18: S&P 500 Breaks Key Support as Fed Minutes Signal More Rate Hikes Ahead
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, Verenigde State van Amerika
SectorHealth Care
Industry-
Websitechampionsoncology.com